Objective:
To understand how researchers are adapting to AI in their work and the factors influencing their trust in AI-generated insights.
Approach:
- Survey Insights: The report surveyed over 3,200 academic and corporate researchers globally regarding AI adoption and trust.
- AI Usage: 58% of researchers now use AI for tasks like literature reviews and data synthesis.
- Trust and Training: Only 22% find AI trustworthy; nearly half feel undertrained in its use.
- AI in Drug Development: AI is significantly impacting data synthesis, target identification, and lead optimization in drug discovery.
Key Findings:
- 58% of researchers use AI, up from 37% in early 2023.
- 61% believe AI will drive new knowledge in the next 2-3 years.
- AI helps in consolidating vast data for drug discovery, saving time.
- Researchers express concerns about the 'black box' problem in AI.
Interpretation:
To build confidence in AI, researchers desire tools that cite sources, are trained on current literature, and demonstrate factual accuracy.
Limitations:
- Trust in AI remains low, with only 22% considering it trustworthy.
- Many researchers feel they lack adequate training to use AI effectively.
Conclusion:
For AI to be effectively integrated into research, it must be transparent, evidence-based, and reliable.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
